Prognostic Stage IV Breast Cancer AJCC v8 Recruiting Phase 2 Trials for Abemaciclib (DB12001)

IndicationStatusPhase
DBCOND0109667 (Prognostic Stage IV Breast Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04305834Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.Treatment